Literature DB >> 7759869

Superantigen-induced anergy in cytotoxic CD8+ T cells.

A Sundstedt1, I Höidén, J Hansson, G Hedlund, T Kalland, M Dohlsten.   

Abstract

This study describes the use of bacterial superantigens to investigate the mechanisms governing peripheral tolerance in CD8+ T cells. Administration of superantigens to mice activates T cells to proliferation, cytokine production, and cytotoxicity, but responding cells subsequently enter a state of hyporesponsiveness or are deleted. Superantigen-induced inactivation has so far mainly been demonstrated for CD4+ T cells. Injection of amounts of the superantigen staphylococcal enterotoxin A (SEA) that are optimal for T cell activation and which induce anergy in CD4+ T cells result in preserved responsiveness in CD8+ CTLs. In contrast, we found that intravenous injection of low concentrations of SEA induced a profound down-regulation of the cytotoxic function in SEA-reactive CD8+ TCR V beta 11+ T cells. No reduction in the number of CD8+V beta 11+ T cells was found, suggesting that anergy and not deletion is the main mechanism for the observed cytotoxic hyporesponsiveness. The cytotoxic anergy was evident 2 days after low-dose priming and remained present 4 wk later, indicating a rapid induction phase and long-lasting persistence. The anergized CD8+ T cell subset expressed lower levels of the alpha-(CD11a) chain of the cell adhesion molecule lymphocyte function-associated Ag 1 (LFA-1) and failed to mediate cytotoxicity, but retained the capacity to proliferate, express IL-2R, produce IFN-gamma, and express granzyme mRNA, which imply a partial defect in TCR-transduced signals. Taken together, these findings suggest that there is a biphasic stimulus-dependent threshold for acquiring responsiveness or anergy in CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7759869

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Gamma interferon expression in CD8(+) T cells is a marker for circulating cytotoxic T lymphocytes that recognize an HLA A2-restricted epitope of human cytomegalovirus phosphoprotein pp65.

Authors:  S A Ghanekar; L E Nomura; M A Suni; L J Picker; H T Maecker; V C Maino
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses.

Authors:  M J Litton; M Dohlsten; J Hansson; A Rosendahl; L Ohlsson; T Kalland; J Andersson; U Andersson
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

3.  Superantigen activation of CD4+ and CD8+T cells from HIV-infected subjects: role of costimulatory molecules and antigen-presenting cells (APC)

Authors:  J Vingerhoets; M Dohlsten; G Penne; R Colebunders; D Sansom; E Bosmans; L Kestens; G Vanham
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

4.  Induction of selective anergy by toxic shock syndrome toxin-1 in CD8+ T cells.

Authors:  Y X Zhao; R Holmdahl; A Tarkowski
Journal:  Immunology       Date:  1997-10       Impact factor: 7.397

5.  Activation of bovine lymphocyte subpopulations by staphylococcal enterotoxin C.

Authors:  W A Ferens; W C Davis; M J Hamilton; Y H Park; C F Deobald; L Fox; G Bohach
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

6.  A mutation of F47 to A in staphylococcus enterotoxin A activates the T-cell receptor Vbeta repertoire in vivo.

Authors:  A Rosendahl; J Hansson; P Antonsson; R P Sékaly; T Kalland; M Dohlsten
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

7.  Superantigen types in Staphylococcus aureus isolated from patients with cystic fibrosis.

Authors:  J Bania; A Dabrowska; B Rózalska; B Sadowska; M Wieckowska-Szakiel; K Korzekwa; A Zarczyńska; J Bystroń; J Chrzanowska; J Molenda
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

8.  ICAM-1 costimulation induces IL-2 but inhibits IL-10 production in superantigen-activated human CD4+ T cells.

Authors:  T Labuda; J Wendt; G Hedlund; M Dohlsten
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

9.  T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.

Authors:  A Sundstedt; S Grundström; M Dohlsten
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

10.  Control of established colon cancer xenografts using a novel humanized single chain antibody-streptococcal superantigen fusion protein targeting the 5T4 oncofetal antigen.

Authors:  Kelcey G Patterson; Jennifer L Dixon Pittaro; Peter S Bastedo; David A Hess; S M Mansour Haeryfar; John K McCormick
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.